(Q67722762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

10 November 2022

author name string

H. R. Hill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728992

10 November 2022

D. K. Kelsey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728992

10 November 2022

L. A. Gonzales

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728992

10 November 2022

H. V. Raff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728992

10 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728992

10 November 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:009012299290046Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

https://api.elsevier.com/content/article/PII:009012299290046Q?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Clinical Immunology and Immunopathology

10 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

1 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

S87-91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence

17 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Blood-transfusion in group-B streptococcal sepsis

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Assessment of the Virulence Factors of Group B Streptococci: Correlation with Sialic Acid Content

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci

10 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Antibodies to major histocompatibility antigens produced by hybrid cell lines

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Protective Efficacy of Hybridoma Type-Specific Antibody Against Experimental Infection with Group-B Streptococcus

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Protection of mice from experimental infection with type III group B Streptococcus using monoclonal antibodies

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

The Effect of Hybridoma Antibody Administration upon Neutrophil Kinetics during Experimental Type III Group B Streptococcal Sepsis

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Effect of fibronectin on IgA-mediated uptake of type III group B streptococci by phagocytes

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections.

10 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

Effects of fibronectin on the interaction of polymorphonuclear leukocytes with unopsonized and antibody-opsonized bacteria

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0090-1229(92)90046-Q

10 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1728992%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference